Methamphetamine use and methicillin-resistant Staphylococcus aureus skin infections

Emerg Infect Dis. 2007 Nov;13(11):1707-13. doi: 10.3201/eid1311.070148.

Abstract

Methicillin-resistant Staphylococcus aureus (MRSA) infections and methamphetamine use are emerging public health problems. We conducted a case-control investigation to determine risk factors for MRSA skin and soft tissue infections (SSTIs) in residents of a largely rural southeastern community in the United States. Case-patients were persons >12 years old who had culturable SSTIs; controls had no SSTIs. Of 119 SSTIs identified, 81 (68.1%) were caused by MRSA. Methamphetamine use was reported in 9.9% of case-patients and 1.8% of controls. After we adjusted for age, sex, and race, patients with MRSA SSTIs were more likely than controls to have recently used methamphetamine (odds ratio 5.10, 95% confidence interval 1.55-16.79). MRSA caused most SSTIs in this population. Transmission of MRSA may be occurring among methamphetamine users in this community.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Amphetamine-Related Disorders / epidemiology
  • Amphetamine-Related Disorders / microbiology*
  • Case-Control Studies
  • Community-Acquired Infections / epidemiology
  • Community-Acquired Infections / microbiology
  • Community-Acquired Infections / prevention & control
  • Disease Outbreaks
  • Drug Resistance, Multiple, Bacterial
  • Electrophoresis, Gel, Pulsed-Field / methods
  • Female
  • Georgia / epidemiology
  • Humans
  • Male
  • Methamphetamine*
  • Methicillin Resistance*
  • Middle Aged
  • Population Surveillance
  • Prospective Studies
  • Soft Tissue Infections / epidemiology*
  • Soft Tissue Infections / microbiology
  • Soft Tissue Infections / prevention & control
  • Staphylococcal Skin Infections / epidemiology*
  • Staphylococcal Skin Infections / microbiology*
  • Staphylococcal Skin Infections / prevention & control
  • Staphylococcus aureus / isolation & purification*

Substances

  • Methamphetamine